Magnetic nanoparticles for biomedical NMR-based diagnostics

• Huilin Shao,
• Tae-Jong Yoon,
• Monty Liong,
• Ralph Weissleder and
• Hakho Lee

Beilstein J. Nanotechnol. 2010, 1, 142–154, doi:10.3762/bjnano.1.17

• ][21][22][23][24][25]. A variety of chemical methods, ranging from traditional wet chemistry to high-temperature thermal decomposition, have been employed to synthesize MNPs. Colloidal iron oxide nanoparticles, which are used as clinical magnetic resonance imaging (MRI) contrast agents, are generally

• , magnetization can vary significantly among nanoparticles of similar sizes. More recently, high quality MNPs have been prepared through thermal decomposition of organometallic precursors, in nonhydrolytic organic solutions containing surfactants [15][16][27][28][29]. Monomers are generated via high-temperature

• thermal decomposition of precursors. Above a supersaturation level, these monomers then aggregate to induce nucleation and nanoparticle growth. By tuning the growth conditions during this procedure (such as precursor choice, monomer concentration, growth temperature and time), it is possible to control

Magnetic coupling mechanisms in particle/thin film composite systems

• Giovanni A. Badini Confalonieri,
• Philipp Szary,
• Durgamadhab Mishra,
• Maria J. Benitez,
• Mathias Feyen,
• An Hui Lu,
• Leonardo Agudo,
• Gunther Eggeler,
• Oleg Petracic and
• Hartmut Zabel

Beilstein J. Nanotechnol. 2010, 1, 101–107, doi:10.3762/bjnano.1.12

• . Experimental Iron oxide NPs were prepared by thermal decomposition of metal-oleate complexes [40]. As-prepared, particles with mean diameter of 20 nm and 7% size distribution were coated with a ~2 nm thick layer of oleic acid and dissolved in toluene. The NP dispersion, with a concentration of approximately 50